@HitenDPatel

Urologic Oncologist @NM_Urology & @ChicagoVAMC @WUSTL, @HopkinsMedicine, @JohnsHopkinsSPH, @brady_urology, @LoyolaUrology @UroOnc Views are my own. #BLM

 Chicago, IL
feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=56321
Joined July 2012
  • Tweets734
  • Following706
  • Followers1.1K
61Media
Hiten Patel retweeted
Tony Su@ztonysuOct 20
Thx to @JAMANetworkOpen for publishing our cost-effectiveness study of periop EV-pembro for cisplatin-ineligible MIBC @MaxKates @SBoorjian @tbivala1 @m_e_nielsen @siadaneshmand @SHPatelMD1 @nirmishsingla @JCensits @akfsurgeon @Sood11 @HitenDPatel @RuchikaTalwarMD @brady_urology
JAMA Network Open@JAMANetworkOpenOct 20
For cisplatin-ineligible muscle-invasive #BladderCancer, perioperative #EnfortumabVedotin plus pembrolizumab with radical cystectomy was associated with improved survival and was cost-effective vs radical cystectomy alone over 10 years. ja.ma/4seltqJ
Line graph showing the probability of being the preferred strategy versus the willingness-to-pay threshold in thousands of dollars per QALY. The intervention curve rises, while the control curve declines, intersecting near 100 thousand.

ALT Line graph showing the probability of being the preferred strategy versus the willingness-to-pay threshold in thousands of dollars per QALY. The intervention curve rises, while the control curve declines, intersecting near 100 thousand.

2
6
1
22
2,857
1/5: I am excited to share that VA STARPORT completed recruitment on Friday October 2, 2026. I am thankful to the Veterans who participated in the study and to our investigators and research teams across the VA who put in an incredible amount of work to get us here. @VAResearch
7
16
3
62
6,199
The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most. For 33 years, PCF has brought science and lived experience together to move research forward. #PCFRetreat26
3
20
1
55
2,641
Hiten Patel retweeted
Andrew Gabrielson
@urogabeSep 22
Oral boards prep hasn't appreciably changed in decades, so I built MockUro, an AI examiner that walks you through ~250 canonical urology cases in Socratic Q&A format, grades your free-form answers across key domains, and adapts your study plan to your weak spots 🧵
11
19
1
104
18,216
Hiten Patel retweeted
Matt Cooperberg
@dr_coopsJun 2
And just like that, an era ended. Neoadj chemo before cystectomy is now a historical footnote #ev304 #keynoteb15 #ASCO26
QianJanieQin@QianJanieQinFeb 27
PRACTICE CHANGING: #KEYNOTEB15/EV304- in #MIBC, periop EV/P led to sig EFS (NR v 48.5m, 24m EFS 79.4 v 66.2%, HR0.53; 0.41-0.7), OS (NR v NR, 24m estimated OS 86.9 v 81.3%, HR 0.65; 0.48-0.89), pCR  (55.8 v 32.5%) benefit v. neoadj gem/cis, supporting EV/P as SOC in this setting
4
7
1
35
10,628
Replying to @NCSAUA
@NCSAUA Board Member Dr. James Brown and the section's Early Career Investigators Showcase nominees @Dr_i_pp_olito and @HitenDPatel selected for presentation at #AUA26.
4
1
7
447
Hiten Patel retweeted
NEJM
@NEJMMay 12
New in our partnership with @DGlaucomflecken: the KEYNOTE-905 trial evaluated enfortumab vedotin plus pembrolizumab as perioperative therapy in patients with muscle-invasive bladder cancer who were ineligible to receive cisplatin. Read the full study for free: nej.md/DrG40
9
98
17
421
104,761
Hiten Patel retweeted
NM Urology
@NM_UrologyMay 11
#AUA26 is just 4 days away! @NorthwesternMed Urology will be strongly represented at this year’s Annual Meeting by our faculty, residents, fellows, and medical students. We’re excited to share our work—and to connect with colleagues from around the world. Meet our representatives and follow along for conference updates!
4
11
1,663
Hiten Patel retweeted
Kari Tikkinen@KariTikkinenApr 22
🔥 POISE-3 Urology published in European Urology 🚨 In the largest randomized placebo-controlled #urology analysis of #TranexamicAcid (TXA), #TXA reduced major #bleeding risk by 37% (from 9.5% to 6.1%) with no clear increase in #thrombosis More at sciencedirect.com/science/ar… #EBM
2
40
3
129
21,291
Hiten Patel retweeted
NM Urology
@NM_UrologyApr 8
🚨 PUBLICATION ALERT 🚨 Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications Authors included: Ashley Ross, MD, PhD, Edward Schaeffer, MD, PhD (@EdwardSchaeffer), Hiten Patel, MD (@HitenDPatel), Jamie Michael, MD, Nicole Handa, MD Publication link: nature.com/articles/s41698-0…
2
4
670
Hiten Patel retweeted
Scott Eggener@uroeggApr 1
For those of us who still do some laparotomies. Small vs Large Bites for Abdominal Midline Incisions jamanetwork.com/journals/jam…
6
23
99
12,441
Analysis with Mitch Huang @NM_Urology @NUFeinbergMed showing uptake of prostate MRI before initial biopsy across the VHA.
JAMA Network Open@JAMANetworkOpen19 Nov 2025
A national VHA study found that prebiopsy prostate MRI utilization increased from 2% in 2015 to 41% in 2023 for veterans with elevated PSA, higher than national benchmarks. ja.ma/3LQPuvx
Two graphs show MRI rates before biopsy from 2015-2023. Graph A: MRI rates by race. Rates for Hispanic/Latino and White individuals are the highest. Graph B: MRI rates by area of residence, with nonrural areas having higher rates than rural areas.

ALT Two graphs show MRI rates before biopsy from 2015-2023. Graph A: MRI rates by race. Rates for Hispanic/Latino and White individuals are the highest. Graph B: MRI rates by area of residence, with nonrural areas having higher rates than rural areas.

4
307
PANIC: PSMA-Ab sensor and destroy Nanoparticle delivery system ligand-based EV-coated Integrated Combo therapy. PCF YI retreat speed networking table 15 #PCFRetreat25 @PCF_Science @SamWashUro @JiaJessieL65499 @UCSFUrology @NM_Urology
1
2
11
793
Purple = prostate peripheral zone, Green = prostate transition zone, White = seminal vehicles, Brown = PANIC, Yellow = bladder, Orange = Tumor and cytokines
2
172
ARE WE WITNESSING THE BEST INDIVIDUAL PERFORMANCE EVER IN THE POSTSEASON ⁉️ 🧊 3 HR 🧊 6 scoreless IP 🧊 10 Ks SHOHEI OHTANI IS REALLY HIM 🐐
59
541
29
4,512
132,724
The hardest lessons after training aren’t always in the OR or clinic. 🙏 I wrote this essay for anyone navigating their first year as an attending. “Unseen Scars” in @JAMA_current 🔗jamanetwork.com/journals/jam…
55
160
33
704
103,236
Hiten Patel retweeted
NM Urology
@NM_Urology29 Aug 2025
The @NorthwesternMed Urology Department is celebrating 125 years of excellence! As we celebrate this historic anniversary, watch as we honor pioneers in the field and reflect on just some of the achievements that exemplify our dedication to better urology. #NMBetter
1
12
46
3,061
📰New in @UrolOncol! 💡Highlights: 1⃣Presence of EPE on MRI predicted prostatectomy outcomes 2⃣Combined biopsy showed the highest rate of grade concordance with prostatectomy 3⃣Our model for adverse surgical pat did not outperform existing nomograms 🔗bit.ly/4kGCuoS
1
5
18
1,388
Hiten Patel retweeted
NEJM
@NEJM1 Jun 2025
Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: nej.md/4mh5RPL @ASCO
18
354
82
807
220,323
So good to see so many friends/colleagues at #AUA25 LV. Now back to reality! @AmerUrological @NM_Urology
1
16
529
Load more